Developing iPS cell-based cancer vaccines.
Created hypoimmunogenic iPS cells via genome editing (Xu et al., Cell Stem Cell 2019).
Translating stem cell discoveries into clinical solutions.
#ISSCR2025
AI and Cancer Evolution Session, Friday 8:30am, Convention Hall B, level 1
@ucsfcancer.bsky.social
@ucsfstemcell.bsky.social
#ISSCR2025
AI and Cancer Evolution Session, Friday 8:30am, Convention Hall B, level 1
@ucsfcancer.bsky.social
@ucsfstemcell.bsky.social